Soken Chemical & Engineering Co., Ltd. (4972.T)
Tokyo, JP
Operating globally with a presence spanning Japan, China, and other international markets, Soken Chemical & Engineering Co., Ltd. specializes in the production and distribution of a diverse portfolio including acrylic pressure-sensitive adhesives, advanced functional polymers, organic microparticles, and various adhesive tapes. These high-performance adhesives find extensive use across industrial sectors like information technology, automotive manufacturing, construction, and electronic and optical components, alongside consumer goods such as household double-sided and packaging tapes, and medical adhesive bandages. The company's advanced functional materials contribute to the development of electronic substrate technologies, inks, paints, display panels, and multi-functional office equipment. Similarly, its functional fine particles are integral components in products ranging from LCD light diffusers, paints, and toners, to anti-blocking film agents, cosmetic formulations, and fiber-reinforced plastics. Beyond these, Soken offers specialized coated items, including double-sided acrylic foam tapes and sheets, alongside innovative nanoimprinting molds and films. Its organic conductive materials serve various cutting-edge applications, such as antistatic and conductive coatings, capacitors, solar cell electrodes, hole transport layers for organic photovoltaics (OPV), and hole injection layers for organic electroluminescent (EL) devices. The company also extends its services to include heating media, thermal boiler systems, and comprehensive plant engineering and maintenance. Established in 1948 and headquartered in Tokyo, Japan, the company initially operated as Sogo Kako Laboratories, Ltd. before adopting its current name, Soken Chemical & Engineering Co., Ltd., in 1953.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.04% | +1.50% | +1.50% | +13.64% | +38.88% | +30.28% | +127.67% | +289.21% | +257.59% | +659.24% | +1,484.11% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+0.7% Q1'26: +5.4% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-7.7% Q1'26: +71.6% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+5.5% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+12.8% ★ Q1'26: +12.2% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+14.8% ★ Q1'26: +13.4% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.1% Q1'26: +0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.52× ★ Q1'26: 0.50× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
28.77B
est: 32.50B (-11.5%)
|
30.05B
est: 30.50B (-1.5%)
|
31.30B
est: 31.60B (-1.0%)
|
28.70B
est: 28.50B (+0.7%)
|
31.49B
est: 31.50B (0.0%)
|
38.64B
est: 37.00B (+4.4%)
|
38.13B
est: 38.50B (-1.0%)
|
41.32B
est: 42.50B (-2.8%)
|
47.63B
est: 48.00B (-0.8%)
|
45.90B
45.90B – 45.90B
-4.4% YoY
|
45.50B
45.50B – 45.50B
-0.9% YoY
|
47.50B
47.50B – 47.50B
+4.4% YoY
|
| EBITDA |
3.22B
est: 4.78B (-32.5%)
|
4.05B
est: 4.48B (-9.6%)
|
3.47B
est: 4.65B (-25.3%)
|
3.42B
est: 4.19B (-18.3%)
|
5.25B
est: 4.63B (+13.3%)
|
4.13B
est: 5.44B (-24.0%)
|
3.92B
est: 5.66B (-30.7%)
|
6.07B
est: 6.01B (+1.0%)
|
8.75B
est: 6.79B (+29.0%)
|
6.49B
6.49B – 6.49B
-4.4% YoY
|
6.43B
6.43B – 6.43B
-0.9% YoY
|
6.72B
6.72B – 6.72B
+4.4% YoY
|
| EBIT |
1.43B
est: 3.07B (-53.5%)
|
2.65B
est: 2.88B (-8.1%)
|
2.11B
est: 2.99B (-29.3%)
|
2.03B
est: 2.70B (-24.5%)
|
3.40B
est: 2.98B (+14.1%)
|
2.23B
est: 3.50B (-36.3%)
|
2.03B
est: 3.64B (-44.1%)
|
3.83B
est: 3.78B (+1.3%)
|
6.35B
est: 4.27B (+48.6%)
|
4.08B
4.08B – 4.08B
-4.4% YoY
|
4.05B
4.05B – 4.05B
-0.9% YoY
|
4.23B
4.23B – 4.23B
+4.4% YoY
|
| Net Income |
765.72M
est: 3.40B (-77.5%)
|
1.96B
est: 2.25B (-12.7%)
|
1.46B
est: 1.50B (-2.5%)
|
1.64B
est: 1.31B (+24.8%)
|
2.72B
est: 2.42B (+12.6%)
|
2.04B
est: 1.51B (+35.5%)
|
1.44B
est: 1.30B (+10.2%)
|
2.63B
est: 2.80B (-6.2%)
|
4.38B
est: 4.40B (-0.6%)
|
4.00B
4.00B – 4.00B
-9.2% YoY
|
3.90B
3.90B – 3.90B
-2.5% YoY
|
4.00B
4.00B – 4.00B
+2.6% YoY
|
| SGA |
5.12B
est: 5.92B (-13.4%)
|
5.62B
est: 5.55B (+1.2%)
|
5.44B
est: 5.75B (-5.4%)
|
5.59B
est: 5.19B (+7.8%)
|
5.77B
est: 5.73B (+0.6%)
|
6.58B
est: 6.74B (-2.4%)
|
6.74B
est: 7.01B (-3.8%)
|
7.38B
est: 7.47B (-1.3%)
|
8.13B
est: 8.44B (-3.7%)
|
8.07B
8.07B – 8.07B
-4.4% YoY
|
8.00B
8.00B – 8.00B
-0.9% YoY
|
8.35B
8.35B – 8.35B
+4.4% YoY
|
| EPS |
46.21
est: 205.20 (-77.5%)
|
118.55
est: 135.75 (-12.7%)
|
88.28
est: 90.50 (-2.5%)
|
99.19
est: 79.10 (+25.4%)
|
165.56
est: 146.05 (+13.4%)
|
123.75
est: 90.90 (+36.1%)
|
86.96
est: 78.65 (+10.6%)
|
158.85
est: 169.05 (-6.0%)
|
264.18
est: 265.40 (-0.5%)
|
241.00
241.00 – 241.00
-9.2% YoY
|
235.00
235.00 – 235.00
-2.5% YoY
|
241.00
241.00 – 241.00
+2.6% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-14 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-13 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-12 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-11 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-08 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-07 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-01 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-27 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-24 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-23 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | WisdomTree Japan SmallCap Dividend Fund DFJ | 0.07% | 278.9K | 0.58% |
| 2 | WisdomTree Japan Equity UCITS ETF - USD Acc DXJZ.L | 0.03% | 213.9K | 0.40% |
| 3 | WisdomTree Japan Equity UCITS ETF DXJ.L | 0.03% | 213.9K | 0.48% |
| 4 | WisdomTree Japan Equity UCITS ETF - CHF Hedged Acc DXJD.SW | 0.03% | 264.1K | 0.45% |
| 5 | WisdomTree Japan Equity UCITS ETF - EUR Hedged Acc DXJF.MI | 0.03% | 243.7K | 0.45% |
| 6 | WisdomTree Japan Equity UCITS ETF - GBP Hedged DXJP.L | 0.03% | 286.1K | 0.45% |
| 7 | WisdomTree Japan Equity UCITS ETF - USD Hedged Acc DXJA.L | 0.03% | 213.9K | 0.48% |
| 8 | Avantis International Small Cap Value ETF AVDV | 0.02% | 3.60M | 0.36% |
| 9 | Avantis International Small Cap Equity ETF AVDS | 0.01% | 43.6K | 0.30% |
| 10 | Avantis Responsible International Equity ETF AVSD | 0.01% | 43.7K | 0.23% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Kiyotaka Takizawa | Director | — | — |
| Koji Tomita | President, Executive Officer & Director | — | — |
| Syuji Okamoto | Managing Executive Officer & Director | — | — |
| Takafumi Hasui | Managing Executive Officer & Director | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4972.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
